Trials / Completed
CompletedNCT01984554
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 551 (actual)
- Sponsor
- American Regent, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
Detailed description
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-09-01
- Completion
- 2014-12-01
- First posted
- 2013-11-14
- Last updated
- 2018-01-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01984554. Inclusion in this directory is not an endorsement.